BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8757271)

  • 1. Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast.
    Wood WC
    Semin Oncol; 1996 Aug; 23(4):446-52. PubMed ID: 8757271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
    Lakhani SR; Audretsch W; Cleton-Jensen AM; Cutuli B; Ellis I; Eusebi V; Greco M; Houslton RS; Kuhl CK; Kurtz J; Palacios J; Peterse H; Rochard F; Rutgers E;
    Eur J Cancer; 2006 Sep; 42(14):2205-11. PubMed ID: 16876991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 4. Lobular neoplasia: morphology and management.
    Jorns J; Sabel MS; Pang JC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast disease: a primer on diagnosis and management.
    Drukker BH
    Int J Fertil Womens Med; 1997; 42(5):278-87. PubMed ID: 9406832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8. The dilemma of in situ carcinoma of the breast.
    Fentiman IS
    Int J Clin Pract; 2001 Dec; 55(10):680-3. PubMed ID: 11777293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease.
    Coombs JH; Hubbard E; Hudson K; Wunderlich C; VanMeter S; Bell JL; Gwin JL
    Am Surg; 1997 Dec; 63(12):1079-83. PubMed ID: 9393256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of ductal carcinoma in situ.
    Talamonti MS
    Semin Surg Oncol; 1996; 12(5):300-13. PubMed ID: 8873317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004].
    Cutuli B; Fourquet A; Luporsi E; Arnould L; Caron Y; Cremoux Pd; Dilhuydy JM; Fondrinier E; Fourme E; Giard-Lefevre S; Blanc-Onfroy ML; Lemanski C; Mauriac L; Sigal-Zafrani B; Tardivon A; This P; Tunon de Lara C; Kirova Y; Fabre N;
    Bull Cancer; 2005 Feb; 92(2):155-68. PubMed ID: 15749645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of ductal carcinoma in situ.
    Barth A; Brenner RJ; Giuliano AE
    West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of lobular carcinoma in situ of the breast.
    Osborne MP; Hoda SA
    Oncology (Williston Park); 1994 Feb; 8(2):45-9; discussion 49, 53-4. PubMed ID: 8167087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
    Collins LC; Tamimi RM; Baer HJ; Connolly JL; Colditz GA; Schnitt SJ
    Cancer; 2005 May; 103(9):1778-84. PubMed ID: 15770688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of in situ carcinoma of the breast: lobular and ductal origin.
    White RE; Bland KI
    R I Med; 1995 Sep; 78(9):242-5. PubMed ID: 7579718
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection.
    Ikeda DM; Birdwell RL; Daniel BL
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):345-56, vii. PubMed ID: 11493424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.